For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the triglyceride-glucose (TyG) index experience faster cognitive decline.

Nonpharmacologic treatments, such as cognitive behavioral therapy, help reduce sleep disorders in patients with multiple sclerosis.

Noninvasive brain stimulation techniques, including transcranial direct current stimulation, are effective nonpharmacologic treatments for insomnia.

Compared to nonmilvet samples, military and veteran participants exhibited lower proportions of diagnosis loss after cognitive processing therapy.

Guidance is provided for the pediatrician regarding the genetic evaluation of developmental delay/intellectual disability.

Intermittent-fasting strategies yield small reductions in body weight compared with an ad libitum diet, according to a study.

Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study.

Depending on the follow-up time, depression/dysthymia may be predicted by different factors, including nationality and any past anxiety disorder.

Counseling was the most common smoking cessation service at US behavioral health centers in 2023, and pharmacotherapy was offered at less than half.

Both high and increasing addictive screen use trajectories are associated with suicidal behaviors and worse mental health in early adolescence.

A total of 27.2 million people of all ages were uninsured in 2024, marking a nonsignificant increase from 25.0 million in 2023.

Add-on therapy and substitution monotherapy are both effective second-line treatments for women with idiopathic generalized epilepsy.